Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (2)
- (-) Neutron Science (1)
- Artificial Intelligence (14)
- Big Data (3)
- Bioenergy (2)
- Biology (4)
- Biotechnology (2)
- Chemical Sciences (1)
- Climate Change (9)
- Computer Science (11)
- Coronavirus (1)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (1)
- Environment (5)
- Exascale Computing (12)
- Frontier (15)
- High-Performance Computing (18)
- Machine Learning (4)
- Materials (5)
- Microscopy (1)
- Nanotechnology (2)
- National Security (3)
- Net Zero (1)
- Nuclear Energy (1)
- Physics (1)
- Quantum Computing (7)
- Quantum Science (4)
- Security (1)
- Simulation (9)
- Software (1)
- Summit (6)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
Hilda Klasky, an R&D staff member in the Scalable Biomedical Modeling group at ORNL, has been selected as a senior member of the Association of Computing Machinery, or ACM.
Using neutrons to see the additive manufacturing process at the atomic level, scientists have shown that they can measure strain in a material as it evolves and track how atoms move in response to stress.